Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (1625)	11/9/1998 1:25:00 PM
From: Dr. John M. de Castro	Read Replies (3) of 2742

rkrw, I'd appreciate it if you would explain your reasoning here. >> The only problem I see in a reverse split (taking the 1 for 20 >> suggestion) is that it will leave little more than 1M shares >> outstanding. With that low a share count, liquidity will likely be >> even worse. The dollar value of the stock (MV) would be the same. But, the bid-ask spread would be smaller. Wouldn't that improve liquidity? In any case, IMHO, the advantages of having CIST listed on the NASDAQ would outweigh any small problem brought about by the split. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next